A Case of Pulmonary Alveolar Proteinosis with Spontaneous Resolution

자연 소실된 폐포단백증 1예

  • Nam, Seung Bum (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Park, Kwang Young (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Lee, Ho Jin (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Jung, Jae Wook (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Choi, Yoon Hee (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Kim, Hyo Seok (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Kim, Cheol Hyeon (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Lee, Jae Cheol (Department of Internal Medicine, Korea Cancer Center Hospital)
  • Received : 2007.06.14
  • Accepted : 2007.08.20
  • Published : 2007.09.30

Abstract

Pulmonary alveolar proteinosis is a rare disorder that is characterized by the abundant accumulation of surfactant-derived material within the alveolar spaces and distal bronchioles. Although the findings of homogenous ground-glass opacities overlaid by thickened septa, which form a "crazy paving" pattern on high-resolution computed tomography, can assist in making a diagnosis, a lung biopsy is usually required. This disorder has a variable clinical course, from spontaneous resolution to respiratory failure and death. While a whole lung lavage has been the standard treatment since the early 1960s, GM-CSF therapy has been attempted based on the recently suggested pathogenetic mechanism. We report a case of pulmonary alveolar proteinosis that resolved spontaneously after an open lung biopsy.

폐포단백증은 폐포에 표면활성제 기원의 인지질이 비정상적으로 다량 침착하는 드문 질병으로 자연 소실에서 호흡부전으로 인한 사망까지 다양한 임상경과를 보인다. 그 원인에 따라 선천성, 특발성, 이차성으로 나눌 수 있는데 GM-CSF의 작용경로의 이상이 중요한 병인으로 여겨지고 있다. 치료의 표준은 기관지 폐포세척술이며, 약 8%정도에서는 자연소실 되는 것으로 보고되었다. 저자들은 진단을 위해 흉강경하 쐐기 절제술을 시행하고 경과 관찰하던 중 자연 소실된 폐포단백증 환자를 경험하였기에 문헌고찰과 함께 이를 보고하는 바이다.

Keywords

References

  1. Rosen SH, Castleman E, Liebow AA. Puhnonary alveolar proteinosis. N Engl J Med 1958;258: 1123-42 https://doi.org/10.1056/NEJM195806052582301
  2. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hndgson G, Gall JA, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteyistic pulmonary pathology Proc Nall Acad Sci USA 1994;91:5692-6
  3. Trapnell BC, Wbitsett JA, Nakata K Pulmonary alveolar pl'oteinosis. N Engl J Med 2003;349:2527-39 https://doi.org/10.1056/NEJMra023226
  4. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: Progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215-35 https://doi.org/10.1164/rccm.2109105
  5. Kim G, Lee SJ, Lee HP, Yoo CG, Han SK, Shim YS, et al. The clinical characteristics of pulmonary alveolar proteinosis: experience at Seoul National University Hospital, and review of the literature. J Korean Med Sci 1999;14:159-64 https://doi.org/10.3346/jkms.1999.14.2.159
  6. Seo JH, Bahk JH. Whole Lung Lavage and Cxtracorporeal Membrane Oxygenation in a Patient with Puhnonary Alveolar nuteincsis and Lung cancer. Korean J Anesthesiol 2005;48:549-52 https://doi.org/10.4097/kjae.2005.48.5.549
  7. Maygarden SJ, Iacocca MY, Funkhouser WK, Novotny DB. Puhnonary alveolar proteincsis: a spectrwn of cytologic, histochemical, and ultrastructural findings in bmnchoalveolar lavage fluid. Diagn Cytopathol 2001;24:389-95 https://doi.org/10.1002/dc.1086
  8. Wang BM, Stem EJ, Schmidt RA, Pierson DJ. Diagnosing pulmonary alveolar proteinosis. A review and an update. Chest 1997;111:460-6 https://doi.org/10.1378/chest.111.2.460
  9. Ioachimescu OC, Kavuru MS. Pulmonary alveolar proteinosis. Chron Respir Dis 2006;3:149-59 https://doi.org/10.1191/1479972306cd101rs
  10. Venkateshiah SD, Yan TD, Banfield TL, Thomassen MJ, Meziane M, Czich C, et al. An open-label trial of granulocyte macmphage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest 2006;130:227-37 https://doi.org/10.1378/chest.130.1.227